10 Oct 2019 10:30
10 October 2019
Omega Diagnostics Group plc
("Omega" or the "Company")
Result of General Meeting
Further to Omega's announcement of 23 September 2019, the Company is pleased to announce the passing of the Resolutions at the General Meeting held earlier today. The Placing and Subscription remain conditional on Admission of the New Ordinary Shares to AIM which is expected to take place at 8.00 a.m. tomorrow.
With effect from Admission the Company will have 150,307,010 Ordinary Shares in issue, with no shares held in treasury. Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.
Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 23 September 2019.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
| www.omegadiagnostics.com |
Colin King, Chief Executive Officer Kieron Harbinson, Group Finance Director |
|
Jag Grewal, Group Sales and Marketing Director |
|
|
|
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/Hannah Boros (Corporate Finance) |
|
Camille Gochez(ECM) |
|
|
|
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
ODX.L (ODX)